Immunogenic Cell Death (ICD)-Related Gene Signature Could Predict the Prognosis of Patients with Diffuse Large B-Cell Lymphoma

Background: Diffuse large B-cell lymphoma (DLBCL) is the most prevalent type of lymphoma that is potentially curable by chemotherapy. Immunogenic cell death (ICD) is regarded as an essential process for the clearance of residual tumor cells. However, the impact of ICD on DLBCL remains unknown. Here,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ping, Liqin, He, Yanxia, Gao, Yan, Wang, Xiaoxiao, Huang, Cheng, Bai, Bing, Huang, Huiqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696383/
https://www.ncbi.nlm.nih.gov/pubmed/36579538
http://dx.doi.org/10.3390/jpm12111840

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696383/
https://www.ncbi.nlm.nih.gov/pubmed/36579538
http://dx.doi.org/10.3390/jpm12111840

Ejemplares similares